Penumbra, Inc. To Present At The Canaccord Genuity 45Th Annual Growth Conference

(MENAFN- PR Newswire)

ALAMEDA, Calif., July 30, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that its management team is scheduled to present at the Canaccord Genuity 45^th Annual Growth Conference on Tuesday, August 12, 2025.

Event:	Canaccord Genuity 45th Annual Growth Conference
Date:	Tuesday, August 12, 2025
Time:	12:30pm ET/9:30am PT

A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at . The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit and connect on Instagram , LinkedIn and X .

Investor Relations
Penumbra, Inc.
[email protected]

SOURCE Penumbra, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN30072025003732001241ID1109864935